Drug Ther Bull. 2010 Aug;48(8):86-8. doi: 10.1136/dtb.2010.08.0041.
Until recently, women in the UK who wanted emergency contraception had two options: an oral hormonal method (levonorgestrel), which is licensed for use up to 3 days after unprotected sexual intercourse; or a copper-bearing intrauterine device (IUD), which can be inserted up to 5 days after unprotected intercourse or up to 5 days after the earliest likely calculated ovulation. Now ulipristal acetate (ellaOne - HRA Pharma), a new oral hormonal emergency contraceptive, has been licensed in the European Union for use within 120 hours (5 days) of unprotected intercourse. Here we assess whether it is an advance for emergency contraception.
直到最近,英国想要采取紧急避孕措施的女性有两种选择:一种是口服激素方法(左炔诺孕酮),其在无保护性交后3天内使用是有许可的;另一种是含铜宫内节育器(IUD),可在无保护性交后5天内或最早可能计算出的排卵后5天内插入。现在,一种新型口服激素紧急避孕药醋酸乌利司他(ellaOne - HRA制药公司生产)已在欧盟获得许可,可在无保护性交后的120小时(5天)内使用。在此,我们评估它是否是紧急避孕方面的一项进步。